Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway ; volume:18 ; number:1 ; day:14 ; month:3 ; year:2023 ; pages:1-16 ; date:12.2023
Chinese medicine ; 18, Heft 1 (14.3.2023), 1-16, 12.2023

Creator: Su, ShiJie
Chen, Gongcan
Gao, Minghuang
Zhong, Guangcheng
Zhang, Zerong
Wei, Dongyun
Luo, Xue
Wang, Qi

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13020-023-00722-y

URN: urn:nbn:de:101:1-2023080421173356936211

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Su, ShiJie
Chen, Gongcan
Gao, Minghuang
Zhong, Guangcheng
Zhang, Zerong
Wei, Dongyun
Luo, Xue
Wang, Qi
SpringerLink (Online service)

Other Objects (12)

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease

Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease

A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway

Alzheimer’s Disease

Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway

Related objects

Reset password